Trade Replimune - REPL CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.06 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.026235% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004012% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 10.68 |
| Open | 10.93 |
| 1-Year Change | -44.94% |
| Day's Range | 10.24 - 10.93 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Sep 6, 2024 | 10.32 | -0.17 | -1.62% | 10.49 | 10.98 | 10.20 |
| Sep 5, 2024 | 10.68 | 0.56 | 5.53% | 10.12 | 10.78 | 10.12 |
| Sep 4, 2024 | 10.41 | 0.28 | 2.76% | 10.13 | 10.75 | 10.13 |
| Sep 3, 2024 | 10.25 | 0.13 | 1.28% | 10.12 | 10.74 | 10.12 |
| Aug 30, 2024 | 10.13 | -0.85 | -7.74% | 10.98 | 11.21 | 10.08 |
| Aug 29, 2024 | 11.02 | 1.13 | 11.43% | 9.89 | 11.27 | 9.82 |
| Aug 28, 2024 | 10.27 | 0.34 | 3.42% | 9.93 | 10.28 | 9.81 |
| Aug 27, 2024 | 9.97 | -0.18 | -1.77% | 10.15 | 10.25 | 9.95 |
| Aug 26, 2024 | 10.24 | 0.09 | 0.89% | 10.15 | 10.53 | 10.08 |
| Aug 23, 2024 | 10.12 | 0.14 | 1.40% | 9.98 | 10.53 | 9.96 |
| Aug 22, 2024 | 10.08 | -0.15 | -1.47% | 10.23 | 10.23 | 9.99 |
| Aug 21, 2024 | 10.23 | -0.40 | -3.76% | 10.63 | 10.68 | 9.93 |
| Aug 20, 2024 | 10.56 | 0.44 | 4.35% | 10.12 | 10.56 | 9.90 |
| Aug 19, 2024 | 10.25 | 0.27 | 2.71% | 9.98 | 10.32 | 9.83 |
| Aug 16, 2024 | 10.08 | -0.03 | -0.30% | 10.11 | 10.26 | 9.95 |
| Aug 15, 2024 | 10.27 | 0.64 | 6.65% | 9.63 | 10.38 | 9.63 |
| Aug 14, 2024 | 9.77 | 0.44 | 4.72% | 9.33 | 9.78 | 9.26 |
| Aug 13, 2024 | 9.70 | 0.44 | 4.75% | 9.26 | 9.71 | 9.22 |
| Aug 12, 2024 | 9.53 | -0.05 | -0.52% | 9.58 | 9.74 | 9.34 |
| Aug 9, 2024 | 9.55 | 0.10 | 1.06% | 9.45 | 9.99 | 9.27 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Replimune Company profile
About Replimune Group Inc
Replimune Group, Inc. is a clinical-stage biotechnology company. The Company is engaged in the field of oncolytic immunotherapy to treat the cancer patients. The Company applies its Immulytic platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The Company is focused on developing a pipeline of oncolytic immunotherapy product candidates to provide clinical benefits to cancer patients. Its product candidates include RP1 (vusolimogene oderparepvec), RP2, and RP3. The Company is focused on Phase 2 clinical trials with its lead product candidate, RP1, in approximately 240 patients with a range of solid tumors.
Financial summary
BRIEF: For the nine months ended 31 December 2021, Replimune Group Inc revenues was not reported. Net loss increased 45% to $86.3M. Higher net loss reflects Research and development increase of 41% to $49.7M (expense), Stock-based Compensation in SGA increase from $4.6M to $12M (expense), General and administrative increase of 38% to $16.1M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$1.34 to -$1.66.
| Industry: | Biotechnology & Medical Research (NEC) |
500 Unicorn Park Dr
WOBURN
MASSACHUSETTS 01801-3377
US
News
Introducing Newsquawk: your new in-platform newsfeed
We are very excited to announce the launch of Newsquawk in the Capital.com platform and app. This new newsfeed is designed to help you get ahead with real-time headlines, personalised stories and in-depth reports – all available directly in the platform and app, where you need them.
14:09, 20 August 2024
Jackson Hole Preview: All eyes on Powell and Gold
The key focus this week will be on Jerome Powell and any insight he may give into the future of monetary policy.
15:24, 19 August 2024
All eyes on inflation: US and UK CPI take centre stage
Just over a month has gone by since the latest CPI data was released in the US and so much has happened since.
14:41, 13 August 2024
European stocks face resistance in their attempt to recover
European stocks struggle to recover as the tech sector faces continued downside pressure in Asia.
13:56, 9 August 2024
Global selloff continues on US economy fears
Thursday’s rise in jobless claims led to a market meltdown in the US stock market as investors became concerned that the Federal Reserve made the wrong decision by keeping rates unchanged on Wednesday.
14:40, 5 August 2024
FOMC PREVIEW
Markets believe the Federal reserve will continue to leave their monetary policy unchanged at the meeting next week.
14:09, 1 August 2024
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024People also watch
Still looking for a broker you can trust?
Join the 640,000+ traders worldwide that chose to trade with Capital.com